Pura Vida Investments’s Regenxbio RGNX Stock Holding History

Pura Vida Investments’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-33,920	Closed	-$1.12M	–	95
2017 Q3	$1.12M	Buy	33,920 +5,100	+18%	+$115K	0.33%	68
2017 Q2	$569K	Buy	+28,820	New	+$558K	0.23%	58

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pura Vida Investments's RGNX Position: Q4 2017 in Review

Pura Vida Investments sold out of Regenxbio (RGNX) in Q4 2017, closing a stake of 33,920 shares — an estimated $1.12M sold.

Pura Vida Investments first reported a position in RGNX in Q2 2017 and held it in 2 quarters. The position peaked at $1.12M in Q3 2017. 108 funds tracked by Wall St. Rank hold RGNX as of Q4 2017.

Pura Vida Investments reported no remaining Regenxbio position as of Q4 2017 after selling out during the quarter.
Pura Vida Investments sold 33,920 Regenxbio shares in Q4 2017, an estimated $1.12M.
Pura Vida Investments first reported a position in Regenxbio in Q2 2017 and held it in 2 quarters.
Pura Vida Investments's Regenxbio position peaked at $1.12M in Q3 2017.
108 funds tracked by Wall St. Rank held Regenxbio as of Q4 2017.

Based on Pura Vida Investments's 13F filing for Q4 2017, filed 14 Feb 2018.